Cargando…
Blood glucose level affects prognosis of patients who received intravenous thrombolysis after acute ischemic stroke? A meta-analysis
BACKGROUND AND OBJECTIVES: Intravenous recombinant tissue plasminogen activator (rtPA) thrombolysis is an effective treatment for acute ischemic stroke. Hyperglycemia is a major risk factor for the occurrence, development, and prognosis of ischemic stroke. This meta-analysis purposefully estimates t...
Autores principales: | Wang, Yue, Jiang, Guannan, Zhang, Jie, Wang, Jingfeng, You, Wanchun, Zhu, Juehua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130663/ https://www.ncbi.nlm.nih.gov/pubmed/37124754 http://dx.doi.org/10.3389/fendo.2023.1120779 |
Ejemplares similares
-
Editorial: the role of diabetes in the pathophysiology and prognosis of ischemic stroke
por: Zhu, Juehua, et al.
Publicado: (2023) -
Effect of admission serum glucose on the clinical prognosis of patients with acute ischemic stroke receiving alteplase intravenous thrombolysis
por: Huang, Pan, et al.
Publicado: (2023) -
Long-term Prognosis of Patients Who Contraindicated for Intravenous Thrombolysis in Acute Ischemic Stroke
por: Lee, Bo-Yeon, et al.
Publicado: (2019) -
Clinical significance of stroke nurse in patients with acute ischemic stroke receiving intravenous thrombolysis
por: Xu, Zhao-Han, et al.
Publicado: (2021) -
Association of triglyceride-glucose index with clinical outcomes in patients with acute ischemic stroke receiving intravenous thrombolysis
por: Toh, Emma M. S., et al.
Publicado: (2022)